Paramount Star Investments Limited reached agreement to acquire 49% of Direct Selling Business of Bioxyne Limited from Bioxyne Limited (ASX:BXN) for $1 million on October 24, 2022. The Direct Selling business comprises of Bioxyne International Pty Limited, Bioxyne International (NZ) Limited, Bioxyne International Sdn Bhd, PT Gamata Utama, Global Treasure New Zealand Limited and New Zealand Nutritional Research Limited.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.006 AUD | 0.00% | -14.29% | -45.45% |
14/05 | Bioxyne to Release Shares from Escrow; Shares Up 17% | MT |
14/05 | Bioxyne Subsidiary, CY Biopharma Enter Partnership to Advance Novel Psilocybin Therapies in Australia | MT |
1st Jan change | Capi. | |
---|---|---|
-45.45% | 8.19M | |
+64.23% | 55.07B | |
-2.31% | 41.79B | |
+44.36% | 40.22B | |
-8.29% | 28.17B | |
+11.97% | 26.28B | |
-21.16% | 18.93B | |
+7.54% | 13.03B | |
+27.17% | 12.26B | |
+25.72% | 12.21B |
- Stock Market
- Equities
- BXN Stock
- News Bioxyne Limited
- Paramount Star Investments Limited reached agreement to acquire 49% of Direct Selling Business of Bioxyne Limited from Bioxyne Limited for $1 million.